Financial Year |
March 31 2023 |
Monetary Funds |
10,556,944,229.92 |
Held-for-trading Financial Assets |
113,100,000.00 |
Notes Receivable |
38,980,755.48 |
Accounts Receivable |
2,718,621,361.68 |
Advances to Suppliers |
738,032,335.48 |
Other Receivables |
27,058,446.32 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
3,124,331,449.91 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
126,916,132.05 |
Total Current Assets |
19,854,516,157.23 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
674,818,541.63 |
Investment Properties |
51,061,178.66 |
Fixed Assetes |
9,554,114,315.44 |
Under-construction Projects |
2,616,250,432.19 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
1,175,122,835.05 |
R&D expenses |
-- |
Goodwill |
19,762,670.46 |
Long-Term Deferred and Prepaid Expenses |
53,845,106.54 |
Deferred Income Tax Assets |
59,031,009.34 |
Other Non-Current Assets |
171,823,122.55 |
Sub-Total of Non-Current Assets |
14,403,797,483.32 |
Total Assets |
34,258,313,640.55 |
Short-Term Loans |
2,929,151,132.14 |
Trading Financial liabilities |
4,952,882.96 |
Notes Payable |
2,060,052,679.84 |
Accounts Payable |
2,219,394,075.66 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
145,480,141.52 |
Taxes Payable |
140,020,829.06 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
32,674,875.19 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
27,995,401.84 |
Other Current Liabilities |
22,536,545.36 |
Sub-Total of Current Liabilities |
7,767,935,293.96 |
Long-term Loans |
1,572,511,053.58 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
320,635,666.79 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
93,948,100.86 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
2,705,760,669.98 |
Total Liabilities |
10,473,695,963.94 |
Paid-In Capital(Or Share Stock) |
4,962,543,897.00 |
Capital Surplus |
3,897,288,222.43 |
Surplus Reserve |
619,752,047.81 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
14,320,341,608.92 |
Minority Stockholder's Interest |
-479,655.59 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
23,785,097,332.20 |
Owner's Equity(Stockholder's Equity) |
23,784,617,676.61 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
34,258,313,640.55 |